Inventor · disambiguated record
Asi Haviv
Also filed as: HAVIV ASI
6 granted patents·31 pending applications·90 citations·filing 2010–2024
83Inventor score
Top patents by PatentIndex Score
37 records- 0193US8598203B2Treatment of Crohn's disease with laquinimodTARCIC NORA·Filed 2010·Granted Dec 3, 2013·68 cites·24 claims
- 0291US11141457B1Oral octreotide therapy and contraceptive methodsAMRYT ENDO INC·Filed 2020·Granted Oct 12, 2021·7 cites·12 claims
- 0391US10682387B2Oral octreotide administered in combination with other therapeutic agentsCHIASMA INC·Filed 2018·Granted Jun 16, 2020·10 cites·3 claims
- 0490US11890316B2Oral octreotide therapy and contraceptive methodsAMRYT ENDO INC·Filed 2021·Granted Feb 6, 2024·3 cites·26 claims
- 0584US2025170204A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 0683US2024041973A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 0783US2025339499A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 0881US2023201302A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 0979US2024016899A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1078US2022339240A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2022·Application pending·0 cites
- 1177US2023173034A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1274US2024123024A1Oral octreotide therapy and contraceptive methodsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1369US2021077569A1Oral octreotide administered in combination with other therapeutic agentsCHIASMA INC·Filed 2020·Application pending·0 cites
- 1468US9161935B2Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapyTARCIC NORA·Filed 2013·Granted Oct 20, 2015·1 cites·21 claims
- 1568US2024050533A1Oral octreotide therapy in combination with digoxin or lisinoprilAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1664US8889661B2Treatment of lupus nephritis using laquinimodHAVIV ASI·Filed 2011·Granted Nov 18, 2014·1 cites·15 claims
- 1762US2021187079A1Oral octreotide for the treatment of diseaseCHIASMA INC·Filed 2017·Application pending·0 cites
- 1862US2016193285A1Oral octreotide administered in combination with other therapeutic agentsCHIASMA INC·Filed 2015·Application pending·0 cites
- 1960US2014200243A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2014·Application pending·0 cites
- 2060US2018000812A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 2159US2017266180A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 2259US2025152674A1Oral octreotide for treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 2359US2014057883A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2013·Application pending·0 cites
- 2458US2016296512A1Treatment of crohn's disease with laquinimodTEVA PHARMA·Filed 2016·Application pending·0 cites
- 2558US2022202911A1Oral octreotide therapy in combination with digoxin or lisinoprilAMRYT ENDO INC·Filed 2020·Application pending·0 cites
- 2658US2017136003A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2017·Application pending·0 cites
- 2757US2017020857A1Treatment of crohn's disease with laquinimodTARCIC NORA·Filed 2016·Application pending·0 cites
- 2855US2015038508A1Treatment of lupus nephritis using laquinimodHAVIV ASI·Filed 2014·Application pending·0 cites
- 2954US2015086549A1Treatment of lupus arthritis using laquinimodHAVIV ASI·Filed 2014·Application pending·0 cites
- 3053US2018140594A1Treatment of lupus nephritis using laquinimodHAVIV ASI·Filed 2018·Application pending·0 cites
- 3152US2017368053A1Treatment of lupus nephritis using laquinimodHAVIV ASI·Filed 2017·Application pending·0 cites
- 3251US2017258780A1Treatment of lupus nephritis using laquinimodHAVIV ASI·Filed 2017·Application pending·0 cites
- 3350US2013184310A1Treatment of lupus arthritis using laquinimodHAVIV ASI·Filed 2013·Application pending·0 cites
- 3449US2017290822A1Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapyTARCIC NORA·Filed 2017·Application pending·0 cites
- 3545US2016213663A1Treatment of lupus arthritis using laquinimodHAVIV ASI·Filed 2016·Application pending·0 cites
- 3645US2011217295A1Treatment of lupus arthritis using laquinimodHAVIV ASI·Filed 2011·Application pending·0 cites
- 3744US2015359788A1Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapyTARCIC NORA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Asi Haviv files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →